Zilico Ltd is a UK based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs.
ZedScan™, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal smear result, increasing diagnostic accuracy and delivering health economic benefits.
Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable and reproducible detection and diagnosis of disease.
Location: United Kingdom, England, Manchester
Member count: 11-50
Total raised: $20.540791M
Founded date: 2006
Investors 2
Date | Name | Website |
- | Venture Fo... | venturefou... |
- | Harwell Ca... | harwellcap... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
02.02.2018 | - | $19M | - | finsmes.co... |
21.06.2012 | - | $1.540791M | The North ... | finsmes.co... |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
02.02.2018 | Zilico Rai... | Zilico, a Manchester, UK-based... | UK | - | finsmes.co... |
21.06.2012 | Zilico Rec... | Zilico Limited, a Sheffield, U... | funding S... | - | finsmes.co... |